401-410 of 534 results for 'consumer data right'

Important developments for offshore diagnostic testing
Insight 01 Sep 2021

In Ariosa Diagnostics, Inc & Ors v Sequenom, Inc [2021] FCAFC 101, the Full Federal Court delivered significant clarity for companies who provide or conduct diagnostic tests. ...

National Electricity and Gas rules update: October 2024
Insight 13 Nov 2024

In our latest update, we examine the progress of new and existing rule change requests to the AEMC across the month of October, as well as take a closer look at how the AEMC is exploring smarter data options for consumers. ...

An update from New Zealand: double patenting win for patentees
Insight 28 Oct 2021

In New Zealand, it is now possible to overcome a double patenting objection by surrendering the parent patent, or by amending the claims of either the parent patent or the divisional application. IPONZ ...

Continuous disclosure obligations in the evolving age of cyberattacks
Insight 02 Nov 2022

This Insight examines the growing need for boards and senior management to consider disclosure obligations in the event of an actual or suspected cyber incident—regardless of their significance—as well as the need to apply an ESG lens to cyber resilience. ...

Payments regulation reform: the Government consults on broad changes to payments system regulation
Insight 13 Jul 2023

The Australian Treasury's recent publication of three significant, and long awaited, payment regulation documents means providers of payments and related services should consider the potential impact of the proposed changes on their business and licensing obligations. ...

ASIC's evolving capital markets report: what it means for industry
Insight 10 Nov 2025

ASIC has released Report 823 'Advancing Australia's evolving capital markets: Discussion paper response report' (the Report), which follows market consultation conducted by ASIC in response to its Feb ...

Down-scheduling CBD and growing Australia's cannabis industry
Insight 09 Nov 2020

The Therapeutics Goods Administration is proposing amendments to the Poisons Standard to permit pharmacists to sell low-dose cannabidiol (CBD) products without a prescription. Businesses intending to import, manufacture and supply cannabis products in the Australian market should monitor these developments closely. ...

Final report on review of Australia’s patent system
Insight 29 Jun 2021

The Federal Government has released the final report on the review of the accessibility of patents for small and medium sized enterprises (SMEs), which follows the phasing-out of the innovation patent system in Australia. ...

Swiss claims and skinny labels: Full Federal Court considers infringement
Insight 27 Aug 2020

An enlarged bench of the Full Federal Court has considered the principles applying to infringement of Swiss-style claims, with the decision potentially limiting the application of Swiss-style claims in the context of so-called second medical use patents, where the allegedly infringing products are ʽskinny-labelled’. ...

Proposed RG 97 stamp duty and PHD private credit changes on the horizon
Insight 03 Dec 2025

ASIC has announced proposed: limited changes to the way stamp duty will be disclosed under Regulatory Guide 97 Disclosing fees and costs in PDSs and periodic statements (RG 97), which are the rules f ...

Refine